3647 results for «718»

Filter By

3647 results

A Cypher implanted 15 years ago

24 May 2019 – From EuroPCR 2019

Consult this session to discover a LIVE demonstration from Institut Cardiovasculaire Paris Sud - Massy, France, regarding Cypher implantation. The patient here is a 85 years-old female with a Cypher implanted 15 years ago, presenting now with exertional angina. Angiogram shows long LAD stenosis. Watch the...

A Cypher implanted 15

TAVI in a bicuspid aortic valve

24 May 2019 – From EuroPCR 2019

TAVI in a bicuspid aortic

A Medina 0,1,0 lesion

24 May 2019 – From EuroPCR 2019

A Medina 0,1,0 lesion

Intermediate risk TAVI

23 May 2019 – From EuroPCR 2019

Intermediate risk TAVI

A randomised trial comparing imaging-guided PCI with Orsiro vs Xience

18 May 2021

Previous clinical trials suggested that ultra-thin strut biodegradable polymer sirolimus-eluting stent (BP-SES) may be associated with lower target lesion failure (TLF) when compared to durable polymer everolimus-eluting stents (DP-EES). However, the possible underlying mechanisms remain unclear. Therefore, the all-comers CASTLE study was designed to assess the...

Authors :

A randomised trial comparing imaging-guided PCI with Orsiro vs Xience

The FLAVOUR Randomized Clinical Trial: Comparison of Fractional Flow Reserve-guided and Intravascular Ultrasound-guided Percutaneous Coronary Intervention in Intermediate Coronary Artery Stenosis

22 Mar 2022

Daniele Giacoppo analyses the main results of the FLAVOUR trial which were presented by Bon-Kwon Koo, from Seoul National University Hospital, South Korea at the American College of Cardiology 2022. 

Daniele Giacoppo

Author

Daniele Giacoppo
The FLAVOUR Randomized Clinical Trial: Comparison of Fractional Flow Reserve-guided and Intravascular Ultrasound-guided Percutaneous Coronary Intervention in Intermediate Coronary Artery Stenosis

Everolimus-eluting stents or bypass surgery for mutivessel coronary artery disease: 10-year outcomes of multicenter randomized controlled BEST trial

20 Sep 2022

Nicola Ryan provides her take on the BEST trial which was presented by Jung-Min Ahn at TCT 2022.

It is a randomised, multicentre, non-inferiority trial comparing PCI with second-generation everolimus-eluting stents and CABG in patients with non-left main multivessel coronary artery disease. At two-year follow-up PCI was shown...

Nicola Ryan

Author

Nicola Ryan
10-Year Outcomes of Multicenter Randomized Controlled BEST Trial: Everolimus-Eluting Stents or Bypass Surgery for Mutivessel CAD
Didn’t find what you were looking for?